-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Prostate cancer is one of the most common types of cancer in men, and it usually develops slowly
But not all patients can be such lucky ones, so doctors need to check patients regularly to determine the changes in tumors
According to the latest research published in Life, urine can take on this important task
In previous studies, Dr.
But in fact, there are still some people who fall into the middle "medium risk" group.
The PUR test they designed will analyze a variety of biomarkers, including prostate cancer-specific RNA transcription factors, and prostate cancer-specific genes that contain probes for 36 genes
Based on the levels of these markers in the patient's urine, researchers can classify patients into risk 1-4
Are these two levels relevant before?
The researchers managed to obtain tumor samples from some patients.
For patients whose Gleason classification is still 1-2, their PUR-4 signals are basically the same
Currently, researchers are trying to conduct a larger cohort study to further verify the results
Reference materials:
[1] Prostate cancer urine test identifies good prognosis patients.
[2] Ball, RY, et al.